Search details
1.
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study.
Breast Cancer Res Treat
; 158(1): 91-97, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27306421
Results
1 -
1
de 1
1
Next >
>>